Environment
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
StateIllinoisIntroduced
HB 5804: MEDICAID-MCO RX PAYMENTS
Dave Vella
HB 5804 status: Introduced — Added Co-Sponsor Rep. Theresa Mah (updated Sep 4, 2026).
Source
LegiScan
Confidence
High
Analysis basis
LegiScan full bill text
01
What this bill does
Official summary alongside an AI-generated read on where it stands and why.
Overall Score
64OUT OF 100
Score:64/100 civic fit
Risk:Low Risk
Impact:Moderate Impact 60/100
Constitutionality95%
Bipartisan70%
Public opinion80%
Bill summary
What changes
Requires Medicaid Managed Care Organizations (MCOs) to reimburse pharmacies that are not designated as 'critical access care' at or above state fee-for-service reimbursement rates.
Who is affected
Medicaid MCOs, pharmacy benefit managers (PBMs), retail pharmacy providers, and Medicaid beneficiaries.
Requirements and enforcement
MCOs must pay both dispensing fees and drug acquisition costs equivalent to the state fee-for-service schedule.
Costs and funding
Potentially increases costs for MCOs and the Medicaid program, though the impact on overall state budget is not quantified.
When it takes effect
Effective date not specified; typical Illinois legislation takes effect January 1st following passage unless otherwise noted.
Potential benefits
Supports pharmacy business sustainability and prevents provider exit from Medicaid networks, ensuring patient access.
Risks and tradeoffs
Potential for MCOs to shift financial burdens elsewhere or reduce the breadth of pharmacy networks to compensate for fixed costs.
What is still unknown
The exact financial impact on MCO operating margins and the potential for pass-through costs to the state government.
02
Impact analysis
✦ AI analysisModeled effects across six domains, estimated from bill text and comparable legislation.
Economy
Positive outlook
70%
Benefits
- Ensures consistent reimbursement for pharmacies
- Reduces financial uncertainty for independent pharmacy providers
- Limits PBMs ability to suppress pharmacy reimbursement below state rates
Risks
- Increases administrative compliance costs for MCOs
- May lead to increased premiums or costs for Medicaid program administration
- Reduces flexibility for MCOs to negotiate pharmacy network rates
Society
Positive outlook
60%
Benefits
- Supports continued access to local pharmacies for Medicaid recipients
- Maintains stability in the pharmacy care delivery infrastructure
- Protects services from disruptions due to underpayment disputes
Risks
- Risk that MCOs could shift costs to other service areas
- Potential for network narrowing if reimbursement pressure mounts
- Changes do not directly address patient copayments or coverage
Technology Industry
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
Civic Accountability
Positive outlook
60%
Benefits
- Establishes clearer, predictable reimbursement standards for MCOs
- Aligns managed care payment practices with public fee-for-service benchmarks
- Reduces opacity in how PBMs compensate pharmacy providers
Risks
- Does not explicitly require public audit reports on PBM payments
- Legislative language relies on existing Department authority
- Implementation relies on the Department's enforcement capacity
Public Health & Safety
Positive outlook
65%
Benefits
- Prevents pharmacy access issues due to unsustainable reimbursement
- Protects the continuity of prescription fulfillment for beneficiaries
- Reduces likelihood of provider network exit in Medicaid
Risks
- No direct impact on clinical pharmacy standards or safety
- Potential for minor disruption during contract renegotiations
- Does not lower cost barriers to obtaining medications
03
How trustworthy & consequential it is
Sourcing already shown above, this is what the analysis found worth flagging.
Source
LegiScan
Official bill text or data from LegiScan.
Confidence
High
Information is complete and verified.
Analysis basis
LegiScan full bill text
Source used for this bill's analysis.
Source note
MCOs may attempt to recoup costs through other provider rate adjustments.
Analysis scope
Does not address PBM transparency beyond reimbursement floors.
04
Where it stands
Official record- IntroducedCurrent
- CommitteeUpcoming
- Chamber votesUpcoming
- Final agreementUpcoming
- GovernorUpcoming
- EnactedUpcoming
05
How it affects your district
✦ Personalized
Set your location
Add your district to see how this bill may affect your community and who to contact.
Your Representatives
Your representatives appear here once you add your location.
06
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.